CTOR Earnings Date: Dec 17, 2026 (Estimated) — Citius Oncology, Inc. Common Stock
XNAS · Healthcare · Drug Manufacturers - Specialty & Generic
Updated
When is CTOR's next earnings date?
Citius Oncology, Inc. Common Stock (CTOR) is expected to report Q4 2026 earnings on Thursday, December 17, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.19 on revenue of $5.8M.
How did CTOR do in its last earnings report?
In its most recent report on Aug 14, 2026 (Q3 2026), Citius Oncology, Inc. Common Stock posted EPS of -$0.08 versus the -$0.07 estimate, a miss of 14.3%. Revenue was $1.5M against a $2.5M estimate. The stock's 1-day post-earnings move was -18.7%.
How much does CTOR stock move after earnings?
CTOR beat EPS estimates in 0 of its last 4 reported quarters. Over the last 8 reports the stock moved an average of 19.6% (up or down) in the day after earnings.
About Citius Oncology, Inc. Common Stock
Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | Q3 2026 | -0.07 | -0.08 | -14.29% | $1.5M | ❌ Miss | -18.66% | -18.25% | -5.91% |
| 2026-05-15 | Q2 2026 | -0.01 | -0.27 | -2600.00% | $1.7M | ❌ Miss | -13.95% | -12.81% | -31.43% |
| 2026-02-13 | Q1 2026 | -0.04 | -0.06 | -50.00% | $3.9M | ❌ Miss | +3.39% | -1.69% | -31.70% |
| 2025-12-23 | Q4 2025 | -0.06 | -0.06 | +0.00% | $0 | ➖ Inline | -9.84% | -21.26% | -13.39% |
| 2025-08-12 | Q3 2025 | — | -0.08 | — | $0 | — | +5.92% | +0.59% | +11.83% |
| 2025-02-14 | Q1 2025 | — | -0.09 | — | $0 | — | -5.60% | +0.00% | -54.31% |
| 2024-12-27 | Q4 2024 | — | -0.14 | — | $0 | — | +7.69% | +48.08% | +21.15% |
| 2024-08-12 | Q3 2024 | — | -0.06 | — | $0 | — | -92.10% | -95.16% | -95.83% |
Showing last 8 quarters.